Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
Aditya Bardia, Wells A. Messersmith, Ebenezer A. Kio, Jordan D. Berlin, Linda T. Vahdat, Gregory A. Masters and 17 more
- Rank
- 19 of 3,031
- Percentile
- top 0.7%
- Where
- Annals of Oncology, 2021
- Citations
- 404
From the 2021 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.